<--- Back to Details
First PageDocument Content
Denosumab / Zoledronic acid / Osteonecrosis of the jaw / Multiple myeloma / Osteoprotegerin / Hypocalcaemia / Alendronic acid / Medicine / Bisphosphonates / Amgen
Date: 2011-01-07 09:23:23
Denosumab
Zoledronic acid
Osteonecrosis of the jaw
Multiple myeloma
Osteoprotegerin
Hypocalcaemia
Alendronic acid
Medicine
Bisphosphonates
Amgen

Xgeva (denosumab) tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 118,54 KB

Share Document on Facebook

Similar Documents

Amgen-Scholars-US Program-OCT2016

Amgen-Scholars-US Program-OCT2016

DocID: 1vl38 - View Document

Amgen-Scholars-Program-Japan-Translated-OCT2016

Amgen-Scholars-Program-Japan-Translated-OCT2016

DocID: 1v8Op - View Document

Amgen-Scholars-Program-Japan-Translated-OCT2016

Amgen-Scholars-Program-Japan-Translated-OCT2016

DocID: 1uS7i - View Document

Student Guide Amgen Scholars Programme Ludwig-Maximilians University Munich Undergraduate Summer Research 2018  European LMU Amgen Scholars Programme

Student Guide Amgen Scholars Programme Ludwig-Maximilians University Munich Undergraduate Summer Research 2018 European LMU Amgen Scholars Programme

DocID: 1uMs7 - View Document

Amgen-Scholars-Japan-Program-A4-OCT2016

Amgen-Scholars-Japan-Program-A4-OCT2016

DocID: 1uKFN - View Document